Decreased Flow-Mediated Dilatation in Children With Type 1 Diabetes: A Systematic Review and Meta-Analysis

Lei Cao1, Miao Hou1, Wanping Zhou1

  • 1Department of Cardiology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.

Angiology
|April 26, 2021
PubMed

Insights

Children with type 1 diabetes (T1DM) show impaired endothelial function, indicated by lower flow-mediated dilatation (FMD). This finding suggests an increased risk for cardiovascular disease in this young population.

Area of Science:

  • Pediatrics
  • Cardiology
  • Endocrinology

Background:

  • Type 1 diabetes (T1DM) is a significant risk factor for cardiovascular disease (CVD).
  • Flow-mediated dilatation (FMD) is a key noninvasive indicator of endothelial function and a predictor of future CVD.
  • The status of FMD in children with T1DM remains a subject of debate.

Purpose of the Study:

  • To conduct a meta-analysis to determine if FMD is impaired in children diagnosed with T1DM.
  • To synthesize existing research to provide a clearer understanding of endothelial function in pediatric T1DM.

Main Methods:

  • A systematic literature search was performed across PubMed, EMBASE, Cochrane Library, and Web of Science.
  • Studies comparing FMD in T1DM children and healthy controls were included.
  • Quality assessment used the Newcastle-Ottawa scale; data were pooled using random-effects models.

Main Results:

  • The meta-analysis included 19 studies with 1245 T1DM patients and 872 healthy controls.
  • Children with T1DM exhibited significantly lower FMD compared to healthy controls (WMD: -2.58; 95% CI: -3.36 to -1.81; P < .001).
  • Meta-regression identified low-density lipoprotein cholesterol levels as a factor influencing the FMD difference.

Conclusions:

  • Children with T1DM demonstrate impaired endothelial function.
  • This impairment suggests a heightened risk for developing cardiovascular disease later in life.
  • Early detection and management of endothelial dysfunction in T1DM children are crucial for CVD prevention.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
74